市場調査レポート

医薬用化学品 - 米国市場における実績と予測

Pharmaceutical Chemicals (US Market & Forecast)

発行 Freedonia Group 商品コード 333518
出版日 ページ情報 英文 497 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
医薬用化学品 - 米国市場における実績と予測 Pharmaceutical Chemicals (US Market & Forecast)
出版日: 2015年06月25日 ページ情報: 英文 497 Pages
概要

米国の医薬用化学品需要は今後年率で6.1%の増加により、2019年には540億ドルに達する見込み。そのおよそ3分の1がジェネリック薬メーカー向けを中心とする商業市場における売上、それ以外が専売薬メーカーからの下請け・受託生産価額から構成されます。

当レポートでは、米国の医薬用化学品市場に注目し、2004年、2009年、2014年の需要推移を検証しながら、2019年および2024年までの市場を原薬 (API) および原材料の別に予測するほか、主要な市場環境指標、産業構造、参入企業51社の市場シェアおよびプロファイルをまとめています。

第1章 エグゼクティブサマリー

第2章 市場環境

  • 概要
  • マクロ経済ファクター
  • 人口動態パターン
  • 医療の動向
    • 健康保険改革
    • 内科疾患
      • 急性疾患
      • 慢性疾患
    • 国民医療費
      • 支出カテゴリー
      • 資金源
    • 医療提供機関
      • 病院
      • 外来診療施設
      • 内科医院
      • 専門養護施設
    • 患者行動
      • 院内行動
      • 外来患者行動
    • 外科手術
  • 医薬品産業の概要
    • 規制
    • 研究開発
    • 製品出荷数
      • 臨床グループ
      • 流通階層
      • 商業的状況

第3章 医薬品用化学品の概要

  • 概要
  • 需要パターンの推移
  • 米国の貿易
  • 国際市場
  • 臨床グループ
  • 商業市場需要
  • 下請け・受託生産
  • 処方薬用化学品
  • 市販薬用化学品

第4章 中枢神経薬

  • 概要
  • 精神治療薬
  • 神経系薬
  • パーキンソン病治療薬
  • リウマチ性関節炎治療薬
  • 眼科用剤
  • その他の中枢神経系薬

第5章 ホルモンおよび関連薬剤

  • 概要
  • 抗がん剤
  • 抗糖尿病薬
  • ホルモン補充治療
  • ビスフォスフォネート (骨吸収抑制) 治療および関連薬剤
  • ホルモン避妊薬
  • その他のホルモン治療および関連薬剤

第6章 心血管薬

  • 概要
  • コレステロール低下薬
  • 抗血栓溶解薬
  • ベータ遮断薬
  • カルシウムチャンネル遮断薬
  • ARB型降圧薬
  • アンジオテンシン変換酵素 (ACE) 阻害薬
  • 利尿薬
  • その他の心血管薬

第7章 抗感染薬

  • 概要
  • 抗ウィルス薬
  • 抗生物質
  • キノロン剤
  • その他の抗生物質

第8章 栄養剤

  • 概要
  • 薬草および関連素材
  • 栄養素
  • バルクミネラル
  • バルクビタミン

第9章 生物製剤

  • 概要
  • ワクチン
  • 血液製剤

第10章 呼吸器系薬

  • 概要
  • 気管支拡張薬
  • 抗ヒスタミン薬
  • 吸入コルチコステロイド薬
  • 鎮咳薬
  • その他の呼吸器系薬

第11章 胃腸薬

  • 概要
  • プロトンポンプ阻害薬
  • 抗嘔吐薬
  • 便秘薬
  • 胃腸抗炎症薬
  • 市販抗酸薬
  • 下痢止め薬
  • その他の胃腸薬

第12章 皮膚科薬

  • 概要
  • 乾癬治療薬
  • 皮膚科抗感染薬
  • 抗外因性疼痛薬
  • 抗ニキビ薬
  • その他の皮膚科薬

第13章 その他の医薬品用化学品

  • 概要
  • 生殖器・泌尿器科薬
  • その他あらゆる医薬品用化学品

第14章 産業構造

  • 概要
  • 市場シェア
  • 競争戦略
  • M&A
  • ライセンシングおよび関連契約
  • マーケティングおよび流通
  • 製造
  • 企業プロファイル
目次
Product Code: 3280

US demand to increase 6.1% annually through 2019

image1

US demand for pharmaceutical chemicals is forecast to rise 6.1 percent annually to $54 billion in 2019. Merchant market sales primarily to generic drug companies will account for nearly one-third of this total. The remainder of demand will consist of the value of pharmaceutical chemicals produced captively or contracted for internal use by makers of proprietary drugs.


New therapies to drive captive & contract market

Although moderated by patent losses, the value of pharmaceutical chemicals obtained from captive and contract production systems will sustain favorable growth, expanding 5.3 percent annually to $36.7 billion in 2019. The introduction of new therapies with enhanced efficacy will underlie gains. For example, in 2014, a total of 41 new molecular entities were approved for marketing by the Food and Drug Administration. Among these approvals were several breakthrough therapies, including blinatumomab for acute lymphoblastic leukemia, ceritinib for late-stage non-small cell lung cancer, ledipasvir/sofosbuvir for chronic hepatitis C, nintedanib and pirfenidone for idiopathic pulmonary fibrosis, and nivolumab for metastatic melanoma. In addition to new molecular entities, growth prospects for proprietary pharmaceutical chemicals will benefit from a number of recent prescription to over-thecounter switches, which extended commercial protection on non-prescription versions of compounds such as esomeprazole magnesium and fluticasone proprionate.

Merchant market demand to grow nearly 8% per annum

Based on the impact of recent and forthcoming drug patent expirations and the expansion of the generic drug industry, merchant market demand for pharmaceutical chemicals will increase 7.8 percent per year to $17.3 billion in 2019. Gains will reflect the introduction and rapid market penetration of generic versions of several blockbuster drugs. Among the pharmaceutical chemicals projected to generate impressive growth in merchant sales due to patent expirations are aripiprazole for bipolar disorder; capecitabine for metastatic breast and colorectal cancer; celecoxib for arthritis; duloxitine HCl for depression, generalized anxiety, and chronic pain; eszopiclone for insomnia; glatiramer acetate for multiple sclerosis; oxycodone HCl for pain management; and raloxifene HCl for osteoporosis.

Study coverage

This upcoming Freedonia industry study, Pharmaceutical Chemicals, presents historical demand data (2004, 2009, 2014) plus forecasts (2019, 2024) by type of active pharmaceutical ingredient (API) and raw material. The study also considers key market environment factors, assesses the industry structure, evaluates company market share, and profiles 51 participants in the US industry.

Table of Contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

  • General
  • Macroeconomic Factors
  • Demographic Patterns
  • Healthcare Trends
    • Health Insurance Reforms
    • Medical Conditions
      • Acute Conditions
      • Chronic Conditions
    • National Health Expenditures
      • Spending Categories
      • Funding Sources
    • Medical Providers
      • Hospitals
      • Outpatient Facilities
      • Physicians
      • Skilled Nursing Homes
    • Patient Activity
      • Hospital Activity
      • Outpatient Activity
    • Surgical Procedures
  • Pharmaceutical Industry Overview
    • Regulation
    • Research & Development
    • Product Shipments
      • Therapeutic Groups
      • Distribution Classes
      • Commercial Status

III. PHARMACEUTICAL CHEMICALS OVERVIEW

  • General
  • Historical Demand Patterns
  • US Trade
  • International Markets
  • Therapeutic Groups
  • Merchant Market Demand
  • Captive & Contract Production
  • Ethical Pharmaceutical Chemicals
  • Over-the-Counter Pharmaceutical Chemicals

IV. CENTRAL NERVOUS SYSTEM CHEMICALS

  • General
  • Psychotherapeutic Agents
    • Antipsychotic Agents
    • Antidepressants
    • Anti-Anxiety Agents
    • OTC Sedatives
  • Neurological Agents
    • Anticonvulsants
    • Multiple Sclerosis Treatments
    • Alzheimer's Disease Treatments
  • Parkinson's Disease Treatments
    • Other Neurological Agents
    • Pain Control Agents
    • Narcotic Analgesics
    • Over-the-Counter Analgesics
    • Ethical Nonsteroidal Anti-Inflammatory Agents
    • Antimigraine Agents
    • Anesthetics
    • Hyaluronic Acid
  • Rheumatoid Arthritis Treatment Chemicals
    • Monoclonal Antibodies
    • Other Arthritis Treatments
  • Ophthalmic Agents
    • Anti-Angiogenic Agents
    • Glaucoma Treatments
    • Other Ophthalmic Agents
  • Other Central Nervous System Chemicals
    • CNS Stimulants
    • Muscle Relaxants
    • Smoking Cessation Compounds
    • Anti-Obesity Agents

V. HORMONES & RELATED CHEMICALS

  • General
  • Anticancer Agents
    • Monoclonal Antibodies
    • Enzyme Inhibitors
    • Growth Factors
    • Immunomodulating Agents
    • Other Anticancer Agents
    • Selected Anticancer Agents in Development
  • Antidiabetic Agents
    • Insulins
    • DPP-4 Inhibitors
    • Biguanides
    • Thiazolidinediones
    • GLP-1 Agonists
    • Sulfonylureas
    • Other Antidiabetic Agents
  • Hormone Replacement Therapies
    • Thyroid Agents
    • Erythropoietins
    • Estrogens
    • Growth Hormones
    • Other Hormone & Related Replacement Therapies
  • Bisphosphonates & Related Agents
  • Hormonal Contraceptives
    • Combination Oral Contraceptives
    • Progestin-Only Pills
    • Other Hormonal Contraceptives
  • Other Hormones & Related Agents

VI. CARDIOVASCULAR CHEMICALS

  • General
  • Cholesterol Reducers
  • Antithrombolytic Agents
    • Patent Expirations
    • Marketed Products
  • Beta Blockers
  • Calcium Channel Blockers
  • Angiotensin II Receptor Antagonists
  • ACE Inhibitors
  • Diuretics
  • Other Cardiovascular Drugs
    • Alpha Adrenergic Agonists
    • Anti-Arrhythmics
    • Bradykinin B2 Receptor Antagonists
    • Cardiac Glycosides
    • Endothelin Receptor Antagonists
    • Vasodilators
    • All Other Cardiovascular Drugs

VII. ANTI-INFECTIVE CHEMICALS

  • General
  • Antiviral Agents
    • Hepatitis Antiviral Agents
    • HIV Antiviral Agents
    • Other Antiviral Agents
  • Antibiotics
    • Penicillins
    • Macrolides
    • Cephalosporins
  • Quinolones
  • Other Antibiotics
    • Oral Antiseptics
    • Other Anti-Infective Agents
    • Antifungal Agents
    • Antimalarial Agents

VIII. NUTRITIONAL CHEMICALS

  • General
  • Herbal & Related Ingredients
    • Herbal & Botanical Extracts
    • Fish Oils
    • Marine & Related Extracts
  • Nutrients
    • Proteins
    • Fibers
    • Probiotics
    • Other Nutrients
  • Bulk Minerals
    • Electrolytes
    • Essential Minerals
    • Trace Minerals
  • Bulk Vitamins
    • Vitamin C
    • Vitamin A
    • B-Group Vitamins
    • Vitamin E
    • Other Vitamins

IX. BIOLOGICAL CHEMICALS

  • General
  • Vaccines
    • Attenuated Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
    • Vaccines in Development
  • Blood Derivatives
    • Plasma Protein Therapies
    • Cellular Components
    • Other Blood-Related Chemicals

X. RESPIRATORY CHEMICALS

  • General
  • Bronchodilators
  • Antihistamines
  • Inhaled Corticosteroids
  • Antitussives
  • Other Respiratory Chemicals
    • Decongestants
    • Expectorants & Mucolytics
    • Omalizumab
    • Leukotriene Receptor Antagonists (LRAs)
    • Selective Phosphodiesterase-4 Inhibitors
    • Ivacaftor
    • Nintedanib
    • Pirfenidone
    • Surfactants

XI. GASTROINTESTINAL CHEMICALS

  • General
  • Proton Pump Inhibitors
  • Anti-Emetic Agents
  • Laxatives
  • Gastrointestinal Anti-Inflammatory Agents
  • OTC Antacids
  • Antidiarrheals
  • Other Gastrointestinal Agents

XII. DERMATOLOGICAL CHEMICALS

  • General
  • Antipsoriatic Agents
  • Dermatological Anti-Infective Agents
    • Antibacterial Compounds
    • Antifungal Compounds
    • Other Dermatological Anti-Infective Compounds
  • External Analgesics
  • Anti-Acne Agents
  • Other Dermatological Chemicals

XIII. OTHER PHARMACEUTICAL CHEMICALS

  • General
  • Genito-Urinary Chemicals
    • Erectile Dysfunction (ED) Treatments
    • Benign Prostate Hyperplasia (BPH) Treatments
    • Overactive Bladder Treatments
  • All Other Pharmaceutical Chemicals
    • Antitransplant Rejection Agents
    • Chelating Agents

XIV. INDUSTRY STRUCTURE

  • General
  • Market Share
  • Competitive Strategies
  • Mergers & Acquisitions
  • Licensing & Related Agreements
  • Marketing & Distribution
  • Manufacturing

Company Profiles

  • Aceto Corporation
  • Ajinomoto Company Incorporated
  • Albemarle Corporation
  • Althea Technologies, see Ajinomoto
  • American Pacific Corporation
  • Aptuit LLC
  • Aurobindo Pharma Limited
  • BASF SE
  • Biocon Limited
  • Cambrex Corporation
  • Carbogen Amcis, see Dishman Pharmaceuticals and Chemicals
  • Cipla Limited
  • Daiichi Fine Chemical, see Kyowa Hakko Kirin
  • Daiichi Sankyo Company Limited
  • Dishman Pharmaceuticals and Chemicals Limited
  • DPx Holdings, see Royal DSM
  • Dr. Reddy's Laboratories Limited
  • DSM Sinochem Pharmaceuticals, see Royal DSM
  • Epax, see FMC
  • Fabbrica Italiana Sintetici SpA
  • FMC Corporation
  • FUJIFILM Holdings Corporation
  • Johnson & Johnson
  • Johnson Matthey plc
  • Kyowa Hakko Kirin Company Limited
  • Lonza Group Limited
  • Lupin Limited
  • Macfarlan Smith, see Johnson Matthey
  • Mallinckrodt plc
  • Noramco, see Johnson & Johnson
  • Novartis AG
  • Novasep Holding SAS
  • Pfanstiehl Incorporated
  • PHF, see Fabbrica Italiana Sintetici
  • Ranbaxy Laboratories, see Sun Pharmaceutical Industries
  • Royal DSM NV
  • Shanghai SynTheAll Pharmaceutical, see WuXi PharmaTech Cayman
  • SI Group Incorporated
  • Sigma-Aldrich Corporation
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • WuXi PharmaTech Cayman Incorporated
  • Additional Companies in the Pharmaceutical Chemicals Industry

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

  • Summary Table

SECTION II -- MARKET ENVIRONMENT

  • 1 Macroeconomic Indicators
  • 2 Resident Population by Age Group
  • 3 Health Insurance Coverage of the US Population, 2004-2014
  • 4 Acute Conditions by Type
  • 5 Chronic Conditions by Type
  • 6 National Health Expenditures by Spending Category
  • 7 National Health Expenditures by Funding Source
  • 8 Medical Providers
  • 9 Patient Activity
  • 10 Pharmaceutical Shipments by Therapeutic Group
  • 11 Pharmaceutical Shipments by Distribution Status
  • 12 Pharmaceutical Shipments by Commercial Status

SECTION III -- PHARMACEUTICAL CHEMICALS OVERVIEW

  • 1 Pharmaceutical Chemicals Demand, 2004-2014
  • 2 US Trade in Pharmaceutical Chemicals
  • 3 World Pharmaceutical Chemicals Merchant Demand
  • 4 Pharmaceutical Chemicals Demand by Therapeutic Group
  • 5 Pharmaceutical Chemicals: Merchant Market Demand by Therapeutic Group
  • 6 Pharmaceutical Chemicals: Captive & Contract Production Output
  • 7 Pharmaceutical Chemicals: Ethical Pharmaceuticals Demand
  • 8 Pharmaceutical Chemicals: Over-the-Counter Pharmaceuticals Demand

SECTION IV -- CENTRAL NERVOUS SYSTEM CHEMICALS

  • 1 Central Nervous System (CNS) Chemicals Demand
  • 2 Psychotherapeutic Chemicals Demand
  • 3 Neurological Chemicals Demand
  • 4 Pain Control Chemicals Demand
  • 5 Rheumatoid Arthritis Treatment Chemicals Demand by Source of Supply
  • 6 Ophthalmic Chemicals Demand
  • 7 Other Central Nervous System Chemicals Demand

SECTION V -- HORMONES & RELATED CHEMICALS

  • 1 Hormones & Related Chemicals Demand
  • 2 Anticancer Chemicals Demand
  • 3 Antidiabetic Chemicals Demand
  • 4 Hormone Replacement Chemicals Demand
  • 5 Bisphosphonates & Related Chemicals Demand by Source of Supply
  • 6 Hormonal Contraceptive Chemicals Demand by Source of Supply
  • 7 Other Hormones & Related Chemicals Demand by Source of Supply

SECTION VI -- CARDIOVASCULAR CHEMICALS

  • 1 Cardiovascular Chemicals Demand
  • 2 Cholesterol-Reducing Chemicals Demand by Source of Supply
  • 3 Antithrombolytic Chemicals Demand by Source of Supply
  • 4 Beta Blocker Chemicals Demand by Source of Supply
  • 5 Calcium Channel Blocker Chemicals Demand by Source of Supply
  • 6 Angiotensin II Antagonist Chemicals Demand by Source of Supply
  • 7 ACE Inhibitor Chemicals Demand by Source of Supply
  • 8 Diuretic Chemicals Demand by Source of Supply
  • 9 Other Cardiovascular Chemicals Demand by Source of Supply

SECTION VII -- ANTI-INFECTIVE CHEMICALS

  • 1 Anti-Infective Chemicals Demand
  • 2 Antiviral Chemicals Demand
  • 3 Antibiotic Chemicals Demand
  • 4 Oral Antiseptics Chemicals Demand by Source of Supply
  • 5 Other Anti-Infective Chemicals Demand

SECTION VIII -- NUTRITIONAL CHEMICALS

  • 1 Nutritional Chemicals Demand
  • 2 Herbal & Related Chemicals Demand
  • 3 Nutrient Chemicals Demand
  • 4 Bulk Minerals Demand
  • 5 Bulk Vitamins Demand

SECTION IX -- BIOLOGICAL CHEMICALS

  • 1 Biological Chemicals Demand
  • 2 Vaccine Chemicals Demand by Source of Supply
  • 3 Blood Derivative Chemicals Demand by Source of Supply

SECTION X -- RESPIRATORY CHEMICALS

  • 1 Respiratory Chemicals Demand
  • 2 Bronchodilator Chemicals Demand by Source of Supply
  • 3 Antihistamine Chemicals Demand
  • 4 Corticosteroid Chemicals Demand
  • 5 Antitussive Chemicals Demand
  • 6 Other Respiratory Chemicals Demand

SECTION XI -- GASTROINTESTINAL CHEMICALS

  • 1 Gastrointestinal Chemicals Demand
  • 2 Proton Pump Inhibitors Chemicals Demand
  • 3 Anti-Emetic Chemicals Demand by Source of Supply
  • 4 OTC Laxative Chemicals Demand
  • 5 Gastrointestinal Anti-Inflammatory Chemicals Demand by Source of Supply
  • 6 OTC Antacid Chemicals Demand
  • 7 Antidiarrheal Chemicals Demand
  • 8 Other Gastrointestinal Chemicals Demand by Source of Supply

SECTION XII -- DERMATOLOGICAL CHEMICALS

  • 1 Dermatological Chemicals Demand
  • 2 Antipsoriatic Chemicals Demand
  • 3 Dermatological Anti-Infective Chemicals Demand
  • 4 External Analgesic Chemicals Demand
  • 5 Anti-Acne Chemicals Demand
  • 6 Other Dermatological Chemicals Demand

SECTION XIII -- OTHER PHARMACEUTICAL CHEMICALS

  • 1 Other Pharmaceutical Chemicals Demand
  • 2 Genito-Urinary Chemicals Demand
  • 3 All Other Pharmaceutical Chemicals Demand

SECTION XIV -- INDUSTRY STRUCTURE

  • 1 Pharmaceutical Chemicals: US Merchant Sales by Company, 2014
  • 2 Selected Acquisitions & Divestitures
  • 3 Selected Cooperative Agreements

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

  • 1 Pharmaceutical Shipments by Therapeutic Group, 2019

SECTION III -- PHARMACEUTICAL CHEMICALS OVERVIEW

  • 1 Pharmaceutical Chemicals Demand by Therapeutic Group, 2019

SECTION IV -- CENTRAL NERVOUS SYSTEM CHEMICALS

  • 1 Central Nervous System Chemicals Demand by Type, 2019

SECTION V -- HORMONES & RELATED CHEMICALS

  • 1 Hormones & Related Chemicals Demand by Type, 2019

SECTION VI -- CARDIOVASCULAR CHEMICALS

  • 1 Cardiovascular Chemicals Demand by Type, 2019

SECTION VII -- ANTI-INFECTIVE CHEMICALS

  • 1 Anti-Infective Chemicals Demand by Type, 2019

SECTION VIII -- NUTRITIONAL CHEMICALS

  • 1 Nutritional Chemicals Demand by Type, 2019

SECTION X -- RESPIRATORY CHEMICALS

  • 1 Respiratory Chemicals Demand by Type, 2019

SECTION XI -- GASTROINTESTINAL CHEMICALS

  • 1 Gastrointestinal Chemicals Demand by Type, 2019

SECTION XII -- DERMATOLOGICAL CHEMICALS

  • 1 Dermatological Chemicals Demand by Type, 2019

SECTION XIV -- INDUSTRY STRUCTURE

  • 1 Pharmaceutical Chemicals: US Merchant Market Share, 2014
Back to Top